Safety and Tolerability of Repeat Courses of IM Alefacept

NCT00233662 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
400
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biogen